Deal net: 6 – 10 February 2017
Posted on 10 February, 2017 by Thierry Heles, editor
The Global Government Venturing deal net rounds up all the latest smaller deals and tracks emerging companies accessing government funds.
Atriva Therapeutics, a Germany-based developer of antiviral therapies, has received an undisclosed amount in seed funding co-led by public-private partnership High-Tech Gründerfonds and Stichting Participatie Artriva. A range of private investors also participated in the round, which will support the advancement of the startup’s therapy for influenza into the clinical development stage.
See more from this Government Report: Germany
Copyright Mawsonia Limited 2010. Please don't cut articles from www.globalgovernmentventuring.com or the PDF and redistribute by email or post to the web without written permission.
Latest magazinePast Issues
Get full online access, the monthly magazine, weekly news alerts, special reports and more.See all subscription options